As of May 6, Alli, the anti-obesity pill, will be sold without a prescription in pharmacies. This drug marketed by GlaxoSmithKline is a less dosed form of Xenical 120mg, available in pharmacies on prescription for ten years. The active principle of Alli, orlistat, limits the absorption of consumed dietary fats which are then eliminated by natural means.
Sold between 50 and 60 euros per month of treatment, Alli is recommended by the GlaxoSmithKline laboratory for a maximum period of six months. In addition to the remedy itself, there is an accompanying program, with nutritional advice and suggestions for physical activities, to encourage patients to adopt a healthier lifestyle.
Although over-the-counter, this medication will require strict dispensing. It is only indicated for people with a body mass index (BMI) greater than or equal to 28 kg / m2. The French Agency for the Safety of Health Products (Afssaps) warns against the misuse of this drug which has contraindications (under 18 years old, pregnant or breastfeeding women, people suffering from chronic malabsorption, etc.) and side effects unwanted (flatulence, stool incontinence). Taking Alli requires medical advice and comprehensive support to achieve lasting weight loss.
